GO:0035782 mature natural killer cell chemotaxis: Directed Migration Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035782 describes the directed movement of a mature natural killer (NK) cell along a chemical concentration gradient, which may be toward higher concentration (positive chemotaxis) or lower concentration (negative chemotaxis).
• Mature NK cells are developmentally mature lymphocytes that express a variety of inhibitory and activating receptors recognizing MHC class and stress-related molecules.
• Chemotaxis of mature NK cells is critical for their recruitment to tissues such as bone marrow, tumors, and sites of infection, and is guided by chemokine gradients including CXCL12/CXCR4.
• The process is regulated by chemokine receptors (e.g., CXCR4, CCR7) and cytokines such as IL-18 that can induce CCR7 expression and enhance migratory capacity.
• Dysregulated NK cell chemotaxis contributes to immune evasion in cancers such as multiple myeloma and to altered antiviral responses in mucosal tissues [2,4].
• Experimental approaches to study this process include chemotaxis assays, live imaging, gene knockout/knock-in models, and CRISPR-based screens targeting chemokine receptors and signaling molecules.
Description
Mature natural killer (NK) cells are innate lymphoid cells that provide rapid defense against virally infected and transformed cells. Their ability to migrate directionally along chemical gradients—termed chemotaxis—is essential for reaching target tissues and executing effector functions. The Gene Ontology term GO:0035782, mature natural killer cell chemotaxis, captures this directed movement of developmentally mature NK cells guided by specific chemical concentration gradients. Understanding this process is fundamental for immunology research, as it links NK cell development, tissue-specific homing, and immune surveillance. Chemotaxis of mature NK cells is not a passive diffusion but an active, receptor-driven process that integrates signals from chemokines, adhesion molecules, and cytokines [6,7]. For example, the CXCL12/CXCR4 axis directs NK cells to the bone marrow, and engineering CXCR4 expression in induced pluripotent stem cell-derived NK cells enhances bone marrow chemotaxis and tumor targeting. Similarly, IL-18 induces CD83+CCR7+ NK helper cells with enhanced migratory properties. These findings highlight the importance of chemotaxis in NK cell-based immunotherapies and in understanding disease pathogenesis [2,6]. Researchers studying GO:0035782 aim to dissect the molecular players, signaling cascades, and regulatory mechanisms that control NK cell migration. This article provides a comprehensive overview of the definition, mechanisms, key genes, disease relevance, and experimental models for studying mature NK cell chemotaxis, with a focus on CRISPR-based approaches for functional validation.
mature natural killer cell chemotaxis At A Glance
| GO ID | GO:0035782 |
|---|---|
| GO term | mature natural killer cell chemotaxis |
| Ontology | biological_process |
| Synonym | activated natural killer cell chemotaxis |
| Definition | The directed movement of a mature natural killer cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). A mature natural killer cell is a natural killer cell that is developmentally mature and expresses a variety of inhibitory and activating receptors that recognize MHC class and other stress related molecules. |
| Major function | Directed migration of mature NK cells along chemokine gradients to target tissues, enabling immune surveillance and effector responses. |
| Related process | Chemotaxis, cell migration, immune cell trafficking |
| Cell type | Mature natural killer cell |
| Taxon range | Metazoa |
What Is GO:0035782?
GO:0035782, mature natural killer cell chemotaxis, is defined as the directed movement of a mature natural killer cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). A mature natural killer cell is a natural killer cell that is developmentally mature and expresses a variety of inhibitory and activating receptors that recognize MHC class and other stress-related molecules.
Why Is mature natural killer cell chemotaxis Important in Cell Biology?
Mature NK cell chemotaxis is essential for the proper distribution and function of NK cells throughout the body. It ensures that NK cells can home to bone marrow, secondary lymphoid organs, inflamed tissues, and tumor sites, where they mediate cytotoxicity and cytokine production [3,6]. Defects in chemotaxis can lead to impaired immune surveillance, increased susceptibility to infections, and poor responses to immunotherapy [2,4]. Therefore, understanding the molecular regulation of GO:0035782 has broad implications for immunology, cancer biology, and infectious diseases [6,7].
• Enables NK cell recruitment to tumor microenvironments, influencing anti-tumor immunity.
• Facilitates NK cell homing to bone marrow, a process enhanced by CXCR4 expression.
• Supports mucosal immune surveillance, as seen in ocular mucosa during adenovirus infection.
• Regulates NK cell interactions with dendritic cells, modulating adaptive immune responses.
• Contributes to the formation of NK helper cells with migratory capacity induced by IL-18.
• Dysregulation is implicated in immune evasion by tumors such as multiple myeloma.
• Provides a target for engineering NK cells in adoptive cell therapy.
• Serves as a model to study chemokine receptor signaling and cytoskeletal dynamics.
• Involves tissue-specific NK cell populations with distinct migratory properties.
• Can be modulated by cytokines and activation signals, affecting NK cell maturation and function [1,7].
What Happens During mature natural killer cell chemotaxis?
Chemokine Sensing and Receptor Activation
In simple terms: The NK cell detects chemical signals in its environment through specialized receptors on its surface.
Mature NK cells express chemokine receptors such as CXCR4 and CCR7 that bind specific chemokines (e.g., CXCL12, CCL19/21) [6,7]. Upon ligand binding, these G-protein-coupled receptors activate intracellular signaling cascades, including PI3K/Akt and Rho GTPase pathways, leading to polarization and directional movement. The expression of these receptors can be regulated by cytokines; for example, IL-18 induces CCR7 on NK cells, converting them into migratory helper cells.
Cytoskeletal Rearrangement and Cell Polarization
In simple terms: The cell changes its shape by reorganizing its internal skeleton to move in the direction of the signal.
Activated chemokine receptors trigger actin polymerization and myosin contraction, establishing a leading edge and a trailing edge. This polarization is essential for directed migration and involves small GTPases such as Rac1 and RhoA. The process is tightly regulated to ensure efficient movement toward the chemokine source.
Adhesion and Extravasation
In simple terms: The NK cell sticks to blood vessel walls and squeezes through them to reach tissues.
Chemotaxis in vivo often requires integrin-mediated adhesion to endothelial cells, followed by transendothelial migration. Chemokines presented on endothelial surfaces activate integrins on NK cells, allowing firm adhesion and subsequent extravasation into tissues. Tissue-specific NK cell populations may use distinct adhesion molecules to home to different organs.
Migration Through Tissue Microenvironments
In simple terms: Once in the tissue, the NK cell navigates through a complex environment following chemical trails.
Within tissues, mature NK cells migrate along chemokine gradients produced by stromal cells, tumor cells, or infected cells [2,4]. For instance, in multiple myeloma, the malignant niche may attract NK cells via chemokines, but tumor cells can also evade NK cell attack by altering these signals. In the ocular mucosa, adenovirus infection dynamically changes NK cell types and their migratory behavior.
Termination and Functional Activation
In simple terms: When the NK cell reaches its target, it stops moving and starts its immune job.
Upon reaching the target site, chemotaxis is downregulated, and NK cells become activated to kill target cells or secrete cytokines such as IFN-gamma [1,5]. Granulysin, a cytolytic protein, is released by NK cells upon target contact, and its expression is linked to NK cell maturation and function. The transition from migration to effector function is critical for effective immune responses.
Key Genes Involved in GO:0035782 mature natural killer cell chemotaxis
The following genes and proteins are key players in mature NK cell chemotaxis, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CXCR4 | Receptor for CXCL12; mediates bone marrow homing and chemotaxis | Engineered expression in iPSC-derived NK cells improves bone marrow chemotaxis and tumor targeting |
| CCR7 | Receptor for CCL19/CCL21; mediates migration to lymph nodes | Induced by IL-18 on NK helper cells; enhances migratory capacity |
| CXCL12 | Chemokine ligand for CXCR4; directs NK cell migration | Gradient source in bone marrow and tumor microenvironment |
| IL18 | Cytokine that induces CCR7 and CD83 on NK cells | Promotes NK helper cell phenotype and chemotaxis |
| CD83 | Maturation marker co-expressed with CCR7 on NK helper cells | Marker of IL-18-induced migratory NK cells |
| GNLY | Granulysin; cytolytic protein released by NK cells | Linked to NK cell maturation and effector function |
| KLRD1 | CD94; inhibitory/activating receptor recognizing MHC class I | Expressed on mature NK cells; may influence activation and migration |
| NCR1 | NKp46; activating receptor on NK cells | Maturation marker; involved in NK cell activation |
| KIR2DL1 | Inhibitory receptor recognizing HLA-C | Expressed on mature NK cells; regulates activation |
| KIR3DL1 | Inhibitory receptor recognizing HLA-B | Expressed on mature NK cells; regulates activation |
| FCGR3A | CD16; mediates antibody-dependent cellular cytotoxicity | Mature NK cell marker; function linked to migration and activation |
| ITGAL | Integrin alpha-L (LFA-1); mediates adhesion | Required for extravasation and tissue migration |
| ITGB2 | Integrin beta-2 (CD18); partners with LFA-1 | Adhesion molecule in NK cell trafficking |
| RAC1 | Rho GTPase; regulates actin cytoskeleton | Essential for cell polarization and chemotaxis |
| RHOA | Rho GTPase; regulates actomyosin contraction | Involved in rear retraction during migration |
| PIK3CA | PI3K catalytic subunit; signaling downstream of chemokine receptors | Mediates Akt activation and chemotaxis |
| AKT1 | Serine/threonine kinase; promotes cell survival and migration | Downstream of PI3K in chemokine signaling |
| PTK2 | Focal adhesion kinase (FAK); regulates adhesion turnover | Important for integrin-mediated migration |
How Is mature natural killer cell chemotaxis Regulated?
Mature NK cell chemotaxis is regulated at multiple levels. Cytokines such as IL-18 can induce the expression of chemokine receptors like CCR7, thereby enhancing migratory capacity. Chemokine receptor signaling is modulated by kinases and phosphatases, including PI3K/Akt and Rho GTPases. Additionally, interactions with dendritic cells can reciprocally influence NK cell activation and migration. Tissue-specific factors, such as the malignant niche in multiple myeloma, can alter chemokine gradients and affect NK cell recruitment. The process is also influenced by the maturation state of NK cells, with mature cells expressing a distinct repertoire of inhibitory and activating receptors that can modulate responsiveness to chemokines.
mature natural killer cell chemotaxis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CXCR4 | Multiple myeloma; bone marrow homing | CXCR4 knockout or knock-in in NK cells; chemotaxis assays |
| CCR7 | Lymph node metastasis; NK helper cell migration | CCR7 overexpression in NK cells; IL-18 stimulation |
| GNLY | Cancer; cytolytic activity | GNLY knockout NK cells; cytotoxicity assays |
| KIR2DL1 | Leukemia; NK cell inhibition | KIR2DL1 knockout NK cells; MHC class I binding assays |
| ITGAL | Leukocyte adhesion deficiency | ITGAL knockout NK cells; adhesion assays |
Multiple Myeloma
In multiple myeloma, the malignant bone marrow niche can attract NK cells but also promote immune evasion by altering chemokine signals. Dysregulated NK cell chemotaxis may contribute to poor NK cell-mediated tumor control, making this pathway a potential therapeutic target.
Adenovirus Infection in Ocular Mucosa
Adenovirus infection in the human ocular mucosa induces dynamic changes in NK cell types and their migratory behavior, potentially as a means of immune evasion by the virus. This highlights the role of NK cell chemotaxis in antiviral defense at mucosal surfaces.
Cancer Immunotherapy
Engineering NK cells to overexpress chemokine receptors such as CXCR4 improves their bone marrow chemotaxis and targeting of resident tumors, demonstrating the therapeutic potential of modulating GO:0035782.
Dendritic Cell-NK Cell Interactions
Reciprocal interactions between dendritic cells and NK cells, induced by oncolytic reovirus infection of tumor cells, enhance antitumor activity and may involve chemotaxis-mediated co-localization.
From mature natural killer cell chemotaxis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CXCR4 mediate NK cell chemotaxis to bone marrow? | CXCR4 knockout NK cells in chemotaxis assays |
| Does IL-18-induced CCR7 enhance NK cell migration? | CCR7 knockout or overexpression in NK cells treated with IL-18 |
| What is the role of granulysin in NK cell function? | GNLY knockout NK cells in cytotoxicity assays |
| How do inhibitory receptors affect NK cell migration? | KIR2DL1 point mutations or knockout NK cells |
| Can engineered CXCR4 improve NK cell tumor targeting? | CXCR4 knock-in in iPSC-derived NK cells |
| What signaling pathways regulate NK cell polarization? | RAC1 or RHOA knockout NK cells with live imaging |
How to Study the mature natural killer cell chemotaxis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transwell chemotaxis assay | Directed migration toward chemokine gradient | Quantify NK cell chemotaxis in vitro |
| Microfluidic chemotaxis device | Cell migration dynamics under controlled gradients | Study real-time chemotaxis and polarization |
| Live-cell imaging | Cell morphology, actin dynamics, and movement | Visualize chemotaxis in real time |
| Flow cytometry | Chemokine receptor expression and maturation markers | Profile NK cell populations before/after migration |
| CRISPR knockout screen | Genes essential for chemotaxis | Identify novel regulators |
| RNA-seq | Transcriptional changes during chemotaxis | Discover signaling pathways |
| Proteomics | Protein expression and phosphorylation changes | Map signaling cascades |
| Adhesion assay | Integrin-mediated adhesion to endothelial cells | Study extravasation steps |
In Vitro Chemotaxis Assays
Transwell or microfluidic chemotaxis assays are used to measure the directed migration of mature NK cells toward chemokine gradients such as CXCL12 or CCL19. These assays allow quantification of migration efficiency and can be combined with inhibitors or gene editing to dissect molecular pathways.
Live-Cell Imaging
Time-lapse microscopy of NK cells expressing fluorescent reporters enables visualization of cell polarization, actin dynamics, and directional movement in real time. This method is valuable for studying the spatiotemporal regulation of chemotaxis.
Flow Cytometry and Receptor Profiling
Flow cytometry is used to assess the expression of chemokine receptors (e.g., CXCR4, CCR7) and maturation markers on NK cells before and after chemotaxis. This helps correlate receptor expression with migratory capacity.
CRISPR-Based Genetic Screens
Pooled CRISPR knockout screens can identify genes required for NK cell chemotaxis by enriching for sgRNAs targeting candidate genes. Such screens have the potential to uncover novel regulators of this process.
How CRISPR Can Be Used to Study GO:0035782 mature natural killer cell chemotaxis
Knockout
CRISPR knockout of candidate genes such as CXCR4, CCR7, or RAC1 in NK cells can abolish or impair chemotaxis, providing causal evidence for their role in GO:0035782. Knockout models are also used in pooled screens to identify novel regulators.
Point Mutation
Introducing point mutations in chemokine receptors (e.g., CXCR4) can dissect specific signaling motifs required for chemotaxis without completely eliminating receptor expression. This approach helps distinguish between ligand binding and downstream signaling defects.
Knock-in
Knock-in of engineered receptors or reporters (e.g., CXCR4 fused to fluorescent protein) allows tracking of receptor localization and function during chemotaxis. Knock-in of human CXCR4 into iPSC-derived NK cells has been shown to improve bone marrow chemotaxis.
Overexpression
Overexpression of chemokine receptors such as CCR7 or CXCR4 in NK cells enhances their migratory capacity toward specific chemokines, as demonstrated by IL-18-induced CCR7 upregulation and engineered CXCR4 expression. This strategy is used to boost NK cell homing in adoptive therapy.
How EDITGENE Supports mature natural killer cell chemotaxis Research
Researchers studying mature natural killer cell chemotaxis-related genes often need to determine whether a candidate gene is causally involved in directed migration or simply correlated with it. CRISPR-based genetic models provide the gold standard for establishing causality by enabling precise knockout, point mutation, knock-in, or overexpression of target genes in NK cells.
Contact EDITGENE today to design your custom CRISPR model for mature natural killer cell chemotaxis research.
Frequently Asked Questions About mature natural killer cell chemotaxis
What is GO:0035782?
GO:0035782 is the Gene Ontology term for mature natural killer cell chemotaxis, defined as the directed movement of a mature NK cell guided by a specific chemical concentration gradient.
What is mature natural killer cell chemotaxis?
It is the process by which developmentally mature NK cells migrate directionally along chemical gradients, such as chemokines, to reach target tissues [1,6].
What genes are involved in mature natural killer cell chemotaxis?
Key genes include CXCR4, CCR7, CXCL12, IL18, RAC1, RHOA, and PIK3CA, among others [6,7].
How is mature NK cell chemotaxis regulated?
It is regulated by chemokine receptors, cytokines like IL-18, and intracellular signaling pathways involving PI3K/Akt and Rho GTPases [6,7].
Why is NK cell chemotaxis important in cancer?
It enables NK cells to infiltrate tumors and mediate anti-tumor activity; dysregulation can lead to immune evasion [2,6].
What diseases are associated with defective NK cell chemotaxis?
Multiple myeloma, adenovirus infection, and other conditions where NK cell trafficking is impaired [2,4].
How can I study NK cell chemotaxis in the lab?
Use Transwell assays, live imaging, flow cytometry, and CRISPR screens to measure and manipulate chemotaxis.
What is the role of CXCR4 in NK cell chemotaxis?
CXCR4 binds CXCL12 and directs NK cells to bone marrow; engineering its expression improves bone marrow chemotaxis.
Can CRISPR be used to study NK cell chemotaxis?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect gene function in chemotaxis.
What services does EDITGENE offer for NK cell chemotaxis research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to NK cell chemotaxis.
Conclusion
Mature natural killer cell chemotaxis (GO:0035782) is a fundamental biological process that governs NK cell trafficking and immune surveillance. Understanding its molecular regulation offers insights into cancer, infectious diseases, and immunotherapy. CRISPR-based models are indispensable for establishing causal roles of specific genes in this process. EDITGENE's comprehensive services empower researchers to accelerate discoveries in NK cell chemotaxis.
References
- 1. Bonavida B et al.. 1993. Natural killer cell subsets: maturation, differentiation and regulation.. Nat Immun 12(4-5):194-208 PMID: 8257826
- 2. Venglar O et al.. 2021. Natural Killer Cells in the Malignant Niche of Multiple Myeloma.. Front Immunol 12:816499 PMID: 35087536
- 3. Lysakova-Devine T et al.. 2014. Tissue-specific NK cell populations and their origin.. J Leukoc Biol 96(6):981-90 PMID: 25246601
- 4. Yawata N et al.. 2016. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection.. Mucosal Immunol 9(1):159-70 PMID: 26080707
- 5. Sparrow E et al.. 2020. Granulysin: The attractive side of a natural born killer.. Immunol Lett 217:126-132 PMID: 31726187
- 6. He X et al.. 2025. Regulatable C-X-C chemokine receptor type 4 in iPSC-derived NK cells improves bone marrow chemotaxis and targeting resident tumor.. Trends Biotechnol 43(7):1668-1689 PMID: 40312161
- 7. Mailliard RB et al.. 2005. IL-18-induced CD83+CCR7+ NK helper cells.. J Exp Med 202(7):941-53 PMID: 16203865
- 8. Prestwich RJ et al.. 2009. Reciprocal human dendritic cell-natural killer cell interactions induce antitumor activity following tumor cell infection by oncolytic reovirus.. J Immunol 183(7):4312-21 PMID: 19734207
